SI1044977T1 - Camptothecin derivatives having antitumor activity - Google Patents

Camptothecin derivatives having antitumor activity

Info

Publication number
SI1044977T1
SI1044977T1 SI9930010T SI9930010T SI1044977T1 SI 1044977 T1 SI1044977 T1 SI 1044977T1 SI 9930010 T SI9930010 T SI 9930010T SI 9930010 T SI9930010 T SI 9930010T SI 1044977 T1 SI1044977 T1 SI 1044977T1
Authority
SI
Slovenia
Prior art keywords
antitumor activity
camptothecin derivatives
camptothecin
derivatives
antitumor
Prior art date
Application number
SI9930010T
Other languages
English (en)
Slovenian (sl)
Inventor
Sergio Penco
Lucio Merlini
Paolo c/o Sigma-Tau Ind.Farm.Riun.S.p.A Carminati
Franco c/o Sigma-Tau Ind.Farm.Riun.S.p.A Zunino
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A., Istituto Nazionale Per Lo Studio E La Cura Dei Tumori filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of SI1044977T1 publication Critical patent/SI1044977T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI9930010T 1999-03-09 1999-03-09 Camptothecin derivatives having antitumor activity SI1044977T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99830124A EP1044977B1 (en) 1999-03-09 1999-03-09 Camptothecin derivatives having antitumor activity

Publications (1)

Publication Number Publication Date
SI1044977T1 true SI1044977T1 (en) 2002-08-31

Family

ID=8243303

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930010T SI1044977T1 (en) 1999-03-09 1999-03-09 Camptothecin derivatives having antitumor activity

Country Status (38)

Country Link
US (2) US6242457B1 (cs)
EP (1) EP1044977B1 (cs)
JP (1) JP4610743B2 (cs)
KR (1) KR100702085B1 (cs)
CN (1) CN1139592C (cs)
AR (1) AR022860A1 (cs)
AT (1) ATE216998T1 (cs)
AU (1) AU774174B2 (cs)
BG (1) BG65032B1 (cs)
BR (1) BR0008840B1 (cs)
CA (1) CA2362760C (cs)
CO (1) CO5180590A1 (cs)
CZ (1) CZ304465B6 (cs)
DE (1) DE69901379T2 (cs)
DK (1) DK1044977T3 (cs)
EA (1) EA003605B1 (cs)
EE (1) EE04679B1 (cs)
EG (1) EG23999A (cs)
ES (1) ES2175919T3 (cs)
HR (1) HRP20010667B1 (cs)
HU (1) HU229506B1 (cs)
IL (2) IL144958A0 (cs)
IS (1) IS2003B (cs)
ME (2) MEP4008A (cs)
MX (1) MXPA01009081A (cs)
NO (1) NO328363B1 (cs)
NZ (1) NZ513393A (cs)
PE (1) PE20001485A1 (cs)
PL (1) PL222208B1 (cs)
PT (1) PT1044977E (cs)
RS (1) RS50405B (cs)
SI (1) SI1044977T1 (cs)
SK (1) SK287561B6 (cs)
TN (1) TNSN00045A1 (cs)
TR (1) TR200102603T2 (cs)
TW (1) TWI272272B (cs)
WO (1) WO2000053607A1 (cs)
ZA (1) ZA200107408B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100374163C (zh) 1999-01-13 2008-03-12 阿尔凯米亚肿瘤学私人有限公司 增强药物功效的组合物
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
FR2794123B1 (fr) * 1999-05-28 2001-07-27 Aventis Pharma Sa Preparation de derives de la camptothecine et de la nothapodytine
US6352996B1 (en) * 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
US20040029906A1 (en) * 2001-07-31 2004-02-12 Michael Christman Inhibitors of dna polymerase sigma
CN1578677A (zh) * 2001-08-27 2005-02-09 美迪泰克研究有限公司 改良的治疗方案
WO2003033525A1 (en) * 2001-10-12 2003-04-24 Debio Recherche Pharmacuetique S.A. Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
ITRM20020306A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.
ITRM20020305A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Camptotecine con anello lattonico modificato.
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
US20080262014A1 (en) * 2004-03-26 2008-10-23 Schran Horst F Use of Camptothecin Derivatives for the Treatment of Proliferative Diseases in a Fixed Dosing Regimen
CN1946421B (zh) 2004-04-27 2013-07-17 威尔斯达特生物制剂公司 使用病毒和喜树碱进行的癌症治疗
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
ITRM20040241A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 20 con antagonisti delle integrine.
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
ITRM20040288A1 (it) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
CN100334089C (zh) * 2004-07-21 2007-08-29 王洋 一种9－硝基喜树碱的生产方法
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
MX2007007212A (es) * 2004-12-15 2007-11-07 Novartis Ag Combinaciones de agentes terapeuticos para el tratamiento del cancer.
US7799921B2 (en) * 2004-12-21 2010-09-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Stereoselective process and crystalline forms of a camptothecin
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
KR20080039344A (ko) 2005-07-14 2008-05-07 웰스테트 바이올로직스 코포레이션 바이러스, 플루오로피리미딘 및 캄토테신을 이용한 암치료방법
CN103784960A (zh) * 2005-07-27 2014-05-14 阿尔卡米亚肿瘤学股份有限公司 使用乙酰透明质酸的治疗方案
ITRM20050418A1 (it) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.
RU2008108894A (ru) * 2005-08-10 2009-09-20 Новартис АГ (CH) Композиции 7-(трет-бутокси)иминометилкамптотецина
AU2006289651B2 (en) * 2005-09-07 2012-07-26 Alchemia Oncology Pty Limited Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
US7888368B2 (en) 2005-12-21 2011-02-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treatment of drug-resistant tumors
CN101421282B (zh) * 2006-02-17 2013-08-14 俄勒冈州由俄勒冈州立大学代表高等教育委员会行使 用长春花生物碱n-氧化物和类似物治疗过度增殖性疾病
AU2007232206B2 (en) 2006-03-30 2013-04-04 Drais Pharmaceuticals, Inc. Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
MX2009008249A (es) * 2007-02-01 2009-08-12 Sigma Tau Ind Farmaceuti Composicion farmaceutica que comprende derivado de camptotecina.
WO2008098701A1 (en) * 2007-02-13 2008-08-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
CN101784277A (zh) 2007-08-01 2010-07-21 希格马托制药工业公司 儿科肿瘤的治疗
EP2096113A1 (en) 2008-02-05 2009-09-02 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. 9-substituted camptothecin derivatives as antitumor compounds
TWI482621B (zh) 2009-12-23 2015-05-01 Sigma Tau Ind Farmaceuti 青蒿素基藥物與其他化學治療劑的抗癌組合物
JP6877049B2 (ja) 2015-09-25 2021-05-26 ゼットワイ セラピューティクス インク．Ｚｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
ZA928771B (en) * 1991-11-15 1993-09-08 Smithkline Beecham Corp Combination chemotherapy
US5614529A (en) * 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
US5972955A (en) * 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
GB9512670D0 (en) * 1995-06-21 1995-08-23 Sod Conseils Rech Applic Camptothecin analogues
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
CA2262745C (en) * 1996-08-19 2006-04-04 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives

Also Published As

Publication number Publication date
CO5180590A1 (es) 2002-07-30
EA200100954A1 (ru) 2002-04-25
SK11642001A3 (sk) 2002-01-07
SK287561B6 (sk) 2011-02-04
CN1343209A (zh) 2002-04-03
NO20014128D0 (no) 2001-08-24
HRP20010667B1 (en) 2003-06-30
EP1044977A1 (en) 2000-10-18
US20010008939A1 (en) 2001-07-19
HRP20010667A2 (en) 2002-08-31
IL144958A (en) 2009-08-03
WO2000053607A1 (en) 2000-09-14
JP2002539128A (ja) 2002-11-19
BG65032B1 (bg) 2006-12-29
BR0008840A (pt) 2002-01-08
EE200100466A (et) 2002-12-16
CN1139592C (zh) 2004-02-25
PE20001485A1 (es) 2000-12-07
AU3160400A (en) 2000-09-28
ZA200107408B (en) 2002-05-29
CA2362760C (en) 2009-08-18
AR022860A1 (es) 2002-09-04
KR20010102519A (ko) 2001-11-15
IS6031A (is) 2001-07-31
NO20014128L (no) 2001-08-24
ME00017B (me) 2010-06-10
EP1044977B1 (en) 2002-05-02
HUP0200210A2 (hu) 2002-05-29
PL222208B1 (pl) 2016-07-29
HU229506B1 (en) 2014-01-28
DE69901379D1 (de) 2002-06-06
CZ304465B6 (cs) 2014-05-21
RS50405B (sr) 2009-12-31
TR200102603T2 (tr) 2002-01-21
AU774174B2 (en) 2004-06-17
US6589939B2 (en) 2003-07-08
JP4610743B2 (ja) 2011-01-12
IL144958A0 (en) 2002-06-30
IS2003B (is) 2005-04-15
NO328363B1 (no) 2010-02-01
PT1044977E (pt) 2002-09-30
TNSN00045A1 (fr) 2005-11-10
DE69901379T2 (de) 2002-11-07
HUP0200210A3 (en) 2004-03-29
ES2175919T3 (es) 2002-11-16
EA003605B1 (ru) 2003-06-26
DK1044977T3 (da) 2002-07-08
CA2362760A1 (en) 2000-09-14
YU64301A (sh) 2005-07-19
MEP4008A (xx) 2010-02-10
EE04679B1 (et) 2006-08-15
EG23999A (en) 2008-03-19
KR100702085B1 (ko) 2007-04-02
PL355094A1 (en) 2004-03-22
TWI272272B (en) 2007-02-01
NZ513393A (en) 2003-04-29
BG105810A (en) 2002-06-28
BR0008840B1 (pt) 2011-12-27
CZ20013077A3 (cs) 2002-01-16
ATE216998T1 (de) 2002-05-15
HK1031222A1 (en) 2001-06-08
MXPA01009081A (es) 2002-08-30
US6242457B1 (en) 2001-06-05

Similar Documents

Publication Publication Date Title
EG23999A (en) Camptothecin derivatives having antitumor activity
EG23817A (en) 4-Phenyl-pyridine derivatives
IL147924A0 (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
IL146100A0 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
IL148167A0 (en) Amino-triazolopyridine derivatives
GC0000183A (en) 3-Phenyl-pyridine derivatives
GC0000338A (en) 5-Phenyl-pyrimidine derivatives
IL145739A0 (en) 13-methyl-erythromycin derivatives
IL148837A0 (en) Isoxazolecarboxamide derivatives
GC0000191A (en) 4-Phenyl-pyrimidine derivatives
HU0003938D0 (en) Quinolin-4-yl derivatives
IL138777A0 (en) Quinolin-4-yl derivatives i
GC0000256A (en) Ethanesulfonyl-piperidine derivatives
GB9925880D0 (en) B-Carboline derivatives
IL147636A0 (en) 3-amino-2-benzyl-1-phenyl-propane derivatives
IL150132A0 (en) Cyclopenteneone derivatives
AP2001002327A0 (en) 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives
PL351407A1 (en) Thio-oxindole derivatives
GB0131034D0 (en) Benzocyclodecane derivatives with antitumor activity
GC0000200A (en) Camptothecin derivatives having antitumor activity
AU5769500A (en) Ucf116 derivatives as antitumor agents
IL146282A0 (en) Thio-oxindole derivatives
GB9907134D0 (en) Antimor napthylcombretastatin derivatives